fbpx

Developed by MaxQ AI, the Accipio products use artificial intelligence for assessment of non-contrast head CT images for intracranial hemorrhage (ICH). Accipio Ix™ is intended for identification and prioritization, while Accipio Ax™ provides slice-level annotation and prioritization for suspected ICH.

Benefits

Increase detection

Greatly increase ICH detection and reduce missed ICHs through near real-time triage, annotation and diagnostic rule-out – because every minute matters for TBI, trauma, and stroke patients.

Clinical confidence

Potentially enhance clinical confidence, including mobilization of ischemic stroke and neurosurgery teams.

Standard of care

Provide the right care readied faster, improving quality to potentially avoid poor patient outcomes and to decrease costs and liability.

Annotations

Provide slice-level annotation, lesion-level annotation and quantification of lesion volume within suspected ICH.

Automatic rule-out

Provide automatic diagnostic ICH rule-out.

Integrated deployment

Deployed through Major CT, AI ecosystem, and PACS channel partners; completely integrated, supported, and serviced from partners you trust.

Address total workflow

To address the total workflow needs of the reader. Not a single algorithm –– an ecosystem designed to benefit the patient, care provider, and facility.

  • Seamless integration
    Zero clicks to Accipio results. Zero need to leave workflow. Zero stored PHI. Zero change to original series.
  • Maximum flexibility
    Rapidly deployed on on-premises and cloud-capable design that grows with your CT and PACS.
  • Accipio Ix
    Automatic, Rapid, Highly Accurate Identification and Prioritization of suspected ICH. Auto-returns rapid case-level summary report of a suspected intracranial hemorrhage to any DICOM compliant CT terminal or PACS worklist, informing if a suspected hemorrhage has been detected.
  • Accipio Ax
    Automatic, Rapid, Highly Accurate Slice-level Annotation & Prioritization of suspected ICH. Auto-returns rapid case-level summary report with SliceMap™ of all CT images with a suspected intracranial hemorrhage to any DICOM compliant CT terminal or PACS worklist, informing if a suspected hemorrhage has been found.

MaxQ AI’s complete ACCIPIO® ICH and Stroke Platform with INSIGHT™ will support the Radiology Department, Emergency Room, Neuroradiology and the Stroke teams with a fully-automated solution. The ACCIPIO® platform will provide tools for identification & prioritization (lx) 1, slice-level annotation (Ax) 2, and triage guidance for suspected ICH presence and diagnostic rule-out3.

1Accipio Ix: FDA Cleared, CE Approved
2Accipio Ax: FDA Cleared, CE Approved
3Diagnostic Rule-Out, Future Device: CAUTION–Investigational device. Limited by United States and international law to investigational use.

Testimonials

“Each month Accipio Ix processes nearly one-thousand head CT scans, including upward of 30 stroke cases per week, at Capital Health. With Accipio Ax, we can now benefit from a comprehensive solution for triage through workflow prioritization and slice-level preview of ICH, including the exclusive Accipio Ax SliceMap™, which guides users rapidly to CT images with suspected ICH.”

Ajay Choudhri, M.D., Chairman of the Department of Radiology at Capital Health Hospitals in New Jersey

“We serve multiple hospitals where we may have several CT head cases with other stat exams to read-with no way of knowing what is the most acute without adding more radiologists – this risk exposure is amplified when a priority stroke case hits the ED. Having an intelligent agent prioritize these cases would increase safety, improve patient care, and inform staffing decisions.”

Mark C DeLano, MD; FACR Advanced Radiology Services, PC; Michigan State University